news-details
Health,Dividend

Ex-Dividend Dates Coming This Week: HealthTech Dividend Stocks

May 16th, 2022 

 

From the desk of The Editor

 

Dear Reader,

 

HealthTechMovers.com has identified several healthtech stocks which are expected to go “Ex-Dividend” starting today, May 16th.  Remember, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment. Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.

 

If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend. 

 

So please keep this in mind.

 

Below is our latest Dividend Report:


Lemaitre Vascular
Symbol: LMAT
Recent Price: $$43.29
Average Analyst Price Target: $50.00 (15.51%)
Market Cap: $$950.19M
Expected Ex-Dividend Date: May 16 2022
Expected Payment Date: Jun 02 2022
Expected Dividend & Yield: 1.08%

Recent Analyst Action: Michael Petusky, analyst at Barrington, reiterates coverage on Lemaitre Vascular (LMAT) in the Healthcare sector with a Buy rating and a price target of $ 50 (2 weeks ago). 

Click for full story >>
--------------------------------------------------------------------------

LifeVantage
Symbol: LFVN
Recent Price: $$4.02
Average Analyst Price Target: $7.00 (74.13%)
Market Cap: $$50.61M
Expected Ex-Dividend Date: May 16 2022
Expected Payment Date: May 31 2022
Expected Dividend & Yield: 0.72%

Recent Analyst Action: Douglas Lane, analyst at Lane Research, reiterates coverage on LifeVantage (LFVN) in the Healthcare sector with a Buy rating and a price target of $ 7 (1 week ago). 

Click for full story >>
--------------------------------------------------------------------------

Laboratory
Symbol: LH
Recent Price: $$244.62
Average Analyst Price Target: $312.20 (27.63%)
Market Cap: $$22.68B
Expected Ex-Dividend Date: May 18 2022
Expected Payment Date: Jun 09 2022
Expected Dividend & Yield: 0.29%

Recent Analyst Action: Eric Coldwell, analyst at Robert W. Baird, reiterates coverage on Laboratory (LH) in the Healthcare sector with a Buy rating and a price target of $ 325 (4 days ago). 

Click for full story >>
--------------------------------------------------------------------------

Sea
Symbol: SE
Recent Price: $$75.40
Average Analyst Price Target: $188.35 (149.80%)
Market Cap: $$42.20B
Expected Ex-Dividend Date: n/a
Expected Payment Date: n/a
Expected Dividend & Yield: 

Recent Analyst Action: Piyush Choudhary, analyst at HSBC, reiterates coverage on Sea (SE) in the Consumer Goods sector with a Buy rating and a price target of $ 145 (1 week ago). 

Click for full story >>
--------------------------------------------------------------------------